Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Other Non-Current Assets (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Other Non-Current Assets for 9 consecutive years, with $412.3 million as the latest value for Q1 2026.

  • For Q1 2026, Other Non-Current Assets rose 12.91% year-over-year to $412.3 million; the TTM value through Mar 2026 reached $412.3 million, up 12.91%, while the annual FY2025 figure was $414.4 million, 11.15% up from the prior year.
  • Other Non-Current Assets hit $412.3 million in Q1 2026 for Select Medical Holdings, down from $414.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $414.4 million in Q4 2025 and bottomed at $291.1 million in Q4 2023.
  • Average Other Non-Current Assets over 5 years is $375.2 million, with a median of $375.4 million recorded in 2024.
  • Year-over-year, Other Non-Current Assets decreased 14.83% in 2023 and then grew 28.09% in 2024.
  • Select Medical Holdings' Other Non-Current Assets stood at $341.7 million in 2022, then fell by 14.83% to $291.1 million in 2023, then rose by 28.09% to $372.8 million in 2024, then rose by 11.15% to $414.4 million in 2025, then dropped by 0.5% to $412.3 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $412.3 million, $414.4 million, and $388.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.